ValuEngine upgraded shares of Capnia, Inc. (NASDAQ:SLNO) from a strong sell rating to a sell rating in a research report sent to investors on Friday morning.
Separately, Maxim Group set a $25.00 price target on Capnia and gave the company a buy rating in a research note on Monday, August 14th.
Capnia (NASDAQ SLNO) traded down 2.36% during mid-day trading on Friday, reaching $2.44. The company’s stock had a trading volume of 84,969 shares. The stock’s market cap is $116.93 million. Capnia has a 12-month low of $0.29 and a 12-month high of $3.00. The firm’s 50 day moving average price is $0.59 and its 200 day moving average price is $0.59.
Capnia (NASDAQ:SLNO) last announced its quarterly earnings results on Friday, August 11th. The company reported ($0.30) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.40) by $0.10. Capnia had a negative return on equity of 69.67% and a negative net margin of 1,389.76%. On average, equities analysts predict that Capnia will post ($0.27) earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This story was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.chaffeybreeze.com/2017/10/07/capnia-inc-slno-upgraded-to-sell-at-valuengine.html.
Capnia Company Profile
Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.
Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.